ArticleDisease markers2022

CCT6A and CHCHD2 Are Coamplified with EGFR and Associated with the Unfavorable Clinical Outcomes of Lung Adenocarcinoma.

Haiwei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.